Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV)’s share price shot up 5.9% on Wednesday . The company traded as high as $3.34 and last traded at $3.25, with a volume of 664,407 shares traded. The stock had previously closed at $3.07.

A number of research firms have weighed in on KTOV. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research note on Saturday, May 14th. Zacks Investment Research raised shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $6.25 price target on the stock in a research note on Wednesday, April 27th.

The firm has a 50-day moving average price of $3.32 and a 200-day moving average price of $3.95. The company’s market cap is $12.68 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.